169 related articles for article (PubMed ID: 37466146)
1. Tumor budding and tumor-infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.
Li Z; Liu L; Wang B; Ying J; He J; Xue L
Thorac Cancer; 2023 Sep; 14(25):2608-2617. PubMed ID: 37466146
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
Liu L; Lin H; Shen G; Liu Y; Qin X; Yuan Y; Wang B; Xue L
BMC Cancer; 2023 Apr; 23(1):370. PubMed ID: 37087442
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma.
Fuchinoue K; Nemoto T; Shimada H; Tochigi N; Igarashi Y; Yajima S; Suzuki T; Oshima Y; Shibuya K
Esophagus; 2020 Apr; 17(2):168-174. PubMed ID: 31595396
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma.
Min BH; Yang JW; Min YW; Baek SY; Kim S; Kim HK; Choi YS; Shim YM; Choi YL; Zo JI
J Gastroenterol Hepatol; 2020 Jun; 35(6):1009-1015. PubMed ID: 31674067
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma.
Wang J; Zhang X; Gan T; Rao NN; Deng K; Yang JL
World J Gastroenterol; 2023 Dec; 29(47):6138-6147. PubMed ID: 38186680
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
Sudo T; Nishida R; Kawahara A; Saisho K; Mimori K; Yamada A; Mizoguchi A; Kadoya K; Matono S; Mori N; Tanaka T; Akagi Y
Ann Surg Oncol; 2017 Nov; 24(12):3763-3770. PubMed ID: 28160141
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
8. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
9. Clinicopathological investigation of lymph node metastasis predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion.
Mitobe J; Ikegami M; Urashima M; Takahashi H; Goda K; Tajiri H
Scand J Gastroenterol; 2013 Oct; 48(10):1173-82. PubMed ID: 23971724
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.
Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J
J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626
[TBL] [Abstract][Full Text] [Related]
11. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.
Lin Z; Chen W; Chen Y; Peng X; Zhu K; Lin Y; Lin Q; Hu Z
Oncotarget; 2016 Nov; 7(46):76261-76273. PubMed ID: 27788489
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
Chen WH; Huang YL; Chao YK; Yeh CJ; Chang HK; Tseng CK; Liu YH
Ann Surg Oncol; 2015 Jan; 22(1):338-43. PubMed ID: 25023545
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Wang J; Jia Y; Wang N; Zhang X; Tan B; Zhang G; Cheng Y
J Transl Med; 2014 Jan; 12():7. PubMed ID: 24397835
[TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
[TBL] [Abstract][Full Text] [Related]
16. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
19. Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study.
Tian D; Huang H; Yang YS; Jiang KY; He X; Guo XG; Chen LQ
World J Surg; 2020 Jan; 44(1):171-178. PubMed ID: 31552458
[TBL] [Abstract][Full Text] [Related]
20. A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma.
Li J; Tang Y; Huang L; Yu Q; Hu G; Zou Y; Yuan X
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27868286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
